Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission has not been previously published, nor is before another journal for consideration (or an explanation has been provided in the field "Comments to the Editor").
- The submission file is in Microsoft Word file format.
- The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed at the end of the manuscript.
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in "About the Journal".
- Competing interest disclosure form(s) is (are) included.
- Authors are kindly invited to suggest at least two potential reviewers (name, affiliation and e-mail) for their manuscript in the "Comments to the Editor" field (Step 1. Submission Process).
To submit a new paper to our journal:
- Register on the Journal website; we encourage you to register also as a Reviewer at the same time;
- Download and follow the Guidelines for Authors;
- Read our Editorial Policies and our Competing Interest policies.
- Log in;
- Click on the "MAKE A SUBMISSION" button to start the online procedure.
To submit a revised version:
- Log in;
- Click on the title of your paper;
- Next to the heading "REVISIONS", upload your revised paper by using the "UPLOAD FILE" button;
- Inform the Editors that a revised version has been uploaded.
Guidelines for Authors
Advice to contributors
All manuscripts must be submitted online through www.reumatismo.org.
The Journal publishes Original Articles on clinical or experimental research, Case Reports, Short Reports, Letters to the Editor, Editorials and Reviews.
Original Articles should concern rheumatology as well as other subjects not strictly related to rheumatology, but of interest to a rheumatological readership; they must concern material never published before (in part or in full).
Requirements: Original Articles must not exceed 3500 words excluding references, tables and figure legends. The total number of figures or tables should not exceed 6.
Case reports and Short reports should describe a condition whose characteristics may provide a contribution of general interest.
Requirements: Case and Short Reports must not be longer than 1800 words, figures, tables and references excluded. 15 references or less and a maximum of 2 figures or tables are allowed.
Letters to the Editor will refer to works already published on the Journal or to topics regarded as interesting.
Requirements: Letters to the Editor must not exceed 800 words, references included.
Editorials on selected subjects are accepted only on demand.
Requirements: Editorials should be limited within 1.000 words with maximum 20 references.
Reviews will deal with current problems of major interests; they should not exceed 4000 words and 5 among tables and figures. Reumatismo publishes also monographic issues composed only of reviews that are commissioned to authors. As a rule, manuscripts should be divided into the following parts:
- introduction, which should present the subject and explain the aims of the work with references to the most up-to-date literature;
- materials and methods, which should inform with precision about the materials (clinical series, etc.) investigated and which should describe the methods employed by the authors;
- discussion, which should include the authors' conclusions;
The same order should be observed also in the Italian-written manuscript.
Manuscripts MUST be accompanied by a cover letter indicating the type of article and including the statement that the article has not been published previously nor submitted elsewhere. Articles express the authors' opinion and do not commit the Journal.
Instructions for the drafting of manuscripts
Reumatismo is a bilingual journal (Italian and English); manuscripts must be written in English and submitted together with the Italian translation. Authors whose native language is not Italian will have their manuscript translated in-house for the printed version of the Journal.
Authors whose native language is not English are strongly advised to have their manuscript checked by a language editing service, or by an English mother-tongue colleague prior to submission.
As an option, PAGEPress offers its own professional copyediting service. Professional copyediting can help authors improve the presentation of their work and increase its chances of being taken on by a publisher. In case you feel that your manuscript needs a professional English language copyediting checking language grammar and style, you can find a reliable revision service at:
Manuscripts must be prepared with a standard word processor (preferably Microsoft Word or OpenOffice). Pages should be in A4 format and numbered. Times New Roman 12 pt is the advised font. Lines should be left numbered in continuum, to make the referees’ work easier, double-spaced and without interruption of page. Every page of the manuscript must be numbered. Manuscripts with single spacing and/or with excessive corrections will be rejected.
The first page should include:
- a running title;
- authors' complete names;
- Institution(s) where the work was done;
- a list of 3-5 key words;
- first name and surname, mailing address, telephone, fax numbers as well as email address of the corresponding Author.
The summary in Italian must be no more than 100 words long and will explain briefly the aim of the work, what was done and the conclusion. The summary must be on the second page and be no more than 250 words long, including the following sections: Objective, Methods, Results, Conclusions. References should include all of the references reported in the text and be compiled numerically according to the order of citation. The surname of every author should be quoted; when there are more than six authors, the first six names should be followed by "et al.". The remaining of the references should be ordered as follows: title of the article, name of the journal abbreviated in accordance with the style of Index Medicus, year, volume number, first and last page numbers, the latter properly abbreviated (e.g., 1023-5 or 1023-31). Italics, boldface and underlining should not be used, as well as capitalization of entire words. For punctuation, editorials, letters, journal supplements and abstracts, authors should refer to the reported examples. Unusual references should be conformed to the styles that can be found in the article "The Vancouver Group. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. JAMA 1993; 269; 2282-6".
References to medical periods
- Standard article
Maddison PJ, Lee L, Reichlin M, Sinclair A, Wasson C, Schemmer G. Anti p-57. A novel association with neonatal lupus. Clin Exp Immunol 1995; 99: 42-8.
- Article in volume supplement
Magni F, Rossoni G, Berti F. BN-52021 protects guinea pig from heart anaphylaxis. Pharmacol Res Commun 1988; Suppl. 5: 75-8.
- Article in number supplement
Gardos G, Cole JO, Haskell D, Marby D, Paine SS, Moore P. The natural history of tardive dyskinesia. J Clin Psychopharmacol 1988; 8 (4 Suppl): 31S-37S.
References to books and monographs
- With one or more authors
Colson JH, Armour WJ. Sports injuries and their treatment. 2nd rev. ed. London: S. Paul, 1986.
- With Editor/s
McCarty DJ, Koopman WJ. Arthritis and allied conditions. A textbook of rheumatology. 12th ed Philadelphia, London: Lea and Fabiger, 1993.
- Chapter in a book
Sledge CB. Biology of the joint. In: Kelley WN, Harris ED jr, Ruddy S, Sledge CB, editors. Textbook of rheumatology, 3rd ed. Philadelphia: Saunders, 1989: 1-21.
Vivan CL, ed. Child abuse and neglet. A medical community response. Proceedings of the First AMA National Conference on Child Abuse and Neglet; 1984 Mar 30-31; Chicago, Chicago: American Medical Association, 1985.
References in the text should be given as number in brackets; Authors cited in the text should have their names entirely quoted if they are one or two; if they are more than two, only the first one should be mentioned, followed by et al.; in such cases the surname, or the two surnames, or et al. should be followed by the relative reference number. Authors are responsible for the accuracy of their references.
Tables should be clear, consistent and necessary for the understanding of the manuscripts. Every table, marked with Roman numerals, should be cited in the text and have a short title; furthermore, its placing in the text should be specified. Figures, accompanied by a short heading, should be marked with Arabic numerals and have a precise indication about their orientation and placing in the text. Tables and figures should carry the title of the manuscripts as well as the relative number on the back. To ensure a clear reproduction of the figures, photocopies are not accepted; photographs and/or slides should be technically perfect. Authors should consider the effect of possible reduction in size of photographs.
Acknowledgments should be placed altogether at the end of the manuscripts, and begin with "The Authors acknowledge".
Please read this advice and download associated files. The International Committee of Medical Journal Editors has recently published in all ICMJE journals an editorial introducing a new “Disclosure Form for Potential Conflict of Interest”, with the aim to establish uniform reporting system, which can go over the existing differences in current formats or editors’ requests. We at PAGEPress Publications welcome this initiative as a possible uniforming, standardizing way to have this important disclosure authorizing the publications of manuscripts. We are therefore asking you to duly fill in the “Uniform Format for Disclosure of Competing Interests in ICMJE Journals” and upload it on the Web site of the PAGEPress journal your work is involved with or email it back to us, in mind to allow PAGEPress to peer-reviewing your work. The document is in Adobe format, it includes instructions to help authors provide the requested information and the completion procedure is user-friendly. Kindly note that the forms should be completed and signed by each author of the work. We wait for the completed form to proceed with publication. Please be informed that if this Disclosure Form is missing, we will not be able to publish your work.
Manuscripts are accepted for publication according to their scientific interest and their relevance to a Rheumatological journal. They are accepted on unquestionable Editor's opinion supported by a written evaluation by at least two anonymous referees. Manuscripts that require revisions are returned by the journal to the corresponding author for improvement. The revised manuscript, edited in .DOC format, should be resubmitted electronically to the Editor-in-Chief (on reumatismo.org) within 8 weeks from the date of receipt by the author. If the revised manuscript is returned to the journal after the allotted time, it will be considered a new submission.
All manuscripts submitted to our journal are critically assessed by external and/or in-house experts in accordance with the principles of peer review (http://www.icmje.org/#peer), which is fundamental to the scientific publication process and the dissemination of sound science. Each paper is first assigned by the Editors to an appropriate Associate Editor who has knowledge of the field discussed in the manuscript. The first step of manuscript selection takes place entirely in-house and has two major objectives: i) to establish the article appropriateness for our journals readership; ii) to define the manuscript priority ranking relative to other manuscripts under consideration, since the number of papers that the journal receives is much greater than it can publish. If a manuscript does not receive a sufficiently high priority score to warrant publication, the editors will proceed to a quick rejection. The remaining articles are reviewed by at least two different external referees (second step or classical peer review). Manuscripts should be prepared according to the Uniform Requirements established by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org/#prepare).
All persons designated as authors should qualify for authorship according to the ICMJE criteria (http://www.icmje.org/ethical_1author.html). Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should only be based on substantial contributions to i) conception and design, or analysis and interpretation of data; and to ii) drafting the article or revising it critically for important intellectual content; and on iii) final approval of the version to be published. These three conditions must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author. Authors should provide a brief description of their individual contributions.
Obligation to Register Clinical Trials (http://www.icmje.org/#clin_trials)
The ICMJE believes that it is important to foster a comprehensive, publicly available database of clinical trials. The ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or concurrent comparison or control groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Medical interventions include drugs, surgical procedures, devices, behavioral treatments, process-of-care changes, etc. Our journals require, as a condition of consideration for publication, registration in a public trials registry. The journal considers a trial for publication only if it has been registered before the enrollment of the first patient. The journal does not advocate one particular registry, but requires authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a non-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include a minimum of data elements (http://www.icmje.org/#clin_trials). For example, ClinicalTrials.gov (http://www.clinicaltrials.gov), sponsored by the United States National Library of Medicine, meets these requirements.
Protection of Human Subjects and Animals in Research
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013 (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available from the World Medical Association (2016 revision, https://www.wma.net/policies-post/wma-statement-on-animal-use-in-biomedical-research) and from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare (http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors). When reporting experiments on ecosystems involving non-native species, Authors are bound to ensure compliance with the institutional and national guide for the preservation of native biodiversity.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.